Piramal Pharma Limited

PPLPHARMA

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 20261,345

    Quarter₹ croreYoY
    Sept 20241,284+29.2%
    Dec 20241,248+21.9%
    Mar 20251,690+10.8%
    Jun 2025970-8.8%
    Sept 20251,127-12.2%
    Dec 20251,196-4.2%
    Mar 20261,489-11.9%
    Jun 20261,125+16.0%
    Sept 20261,345+19.3%
  • ₹ crore

    Sept 2026138

    Quarter₹ crore
    Sept 2024106
    Dec 202425
    Mar 202540
    Jun 2025181
    Sept 2025202
    Dec 202596
    Mar 2026184
    Jun 2026115
    Sept 2026138
  • ₹ crore

    Sept 20261,483

    Quarter₹ crore
    Sept 20241,391
    Dec 20241,273
    Mar 20251,729
    Jun 20251,151
    Sept 20251,329
    Dec 20251,292
    Mar 20261,673
    Jun 20261,240
    Sept 20261,483
  • Cost structure
  • ₹ crore

    Sept 2026218

    Quarter₹ crore
    Sept 2024177
    Dec 2024174
    Mar 2025199
    Jun 2025202
    Sept 2025189
    Dec 2025188
    Mar 2026167
    Jun 2026216
    Sept 2026218
  • ₹ crore

    Sept 20261,259

    Quarter₹ crore
    Sept 20241,115
    Dec 20241,114
    Mar 20251,365
    Jun 20251,008
    Sept 20251,082
    Dec 20251,110
    Mar 20261,275
    Jun 20261,090
    Sept 20261,259
  • Exceptional items and tax
  • ₹ crore

    Sept 2026225

    Quarter₹ crore
    Sept 2024276
    Dec 2024159
    Mar 2025364
    Jun 2025143
    Sept 2025247
    Dec 2025155
    Mar 2026332
    Jun 2026149
    Sept 2026225
  • ₹ crore

    Sept 202654

    Quarter₹ crore
    Sept 202466
    Dec 202441
    Mar 202587
    Jun 202529
    Sept 202551
    Dec 202526
    Mar 202670
    Jun 202636
    Sept 202654
  • Profit
  • ₹ crore

    Sept 2026171

    Quarter₹ croreYoY
    Sept 2024210+172.2%
    Dec 2024119+59.8%
    Mar 2025277+1.5%
    Jun 2025113+32.7%
    Sept 2025196-6.5%
    Dec 2025129+8.5%
    Mar 2026262-5.6%
    Jun 2026113+0.3%
    Sept 2026171-13.0%
  • Per share
  • ₹ per share

    Sept 20261.29

    Quarter₹ per share
    Sept 20241.59
    Dec 20240.90
    Mar 20252.09
    Jun 20250.85
    Sept 20251.48
    Dec 20250.97
    Mar 20261.97
    Jun 20260.85
    Sept 20261.29
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
1,2841,2481,6909701,1271,1961,4891,1251,345
Revenue YoY+29.2%+21.9%+10.8%-8.8%-12.2%-4.2%-11.9%+16.0%+19.3%
106254018120296184115138
1,3911,2731,7291,1511,3291,2921,6731,2401,483
Cost structure
177174199202189188167216218
1,1151,1141,3651,0081,0821,1101,2751,0901,259
Exceptional items and tax
276159364143247155332149225
664187295126703654
Profit
210119277113196129262113171
Net profit YoY+172.2%+59.8%+1.5%+32.7%-6.5%+8.5%-5.6%+0.3%-13.0%
Per share
1.590.902.090.851.480.971.970.851.29

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.